Dr. Todd Hobbs and Dr. Henriette Mersebach, Novo Nordisk in North America
How a Drug is Born
Tuesday, October 20th, 2015, 4 – 5 pm, SCP101
The first in a series of lectures to highlight the recent partnership between Novo Nordisk and TCNJ, this lecture will take the audience through the many steps required in the process of drug discovery through approval. Scientific leaders from Novo Nordisk, Inc. in Plainsboro, NJ will share their insights gathered from many years of experience in product approvals to explain how a chemical entity moves from the lab to animal and human studies, full-scale clinical testing, and finally to regulatory approval from the FDA to be marketed as a new pharmaceutical product. The speakers will also highlight the many synergies between areas of scientific study available at TCNJ and the relevance of these areas to the drug development process.